Drug Trial Radar · NCT06976268
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
550
Planned (sponsor's estimate)
Start
May 28, 2025
Primary completion
Aug 2027
Study completion Sep 2028
Sponsor
- Lead sponsor
- Biohaven Therapeutics Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease. The study will consist of a 48-week double-blind treatment phase followed by a 48-week open-label phase.
Conditions
- Parkinson Disease
Interventions
BHV-8000 10mgDrug
taken orally
BHV-8000 20 mgDrug
taken orally
PlaceboDrug
taken orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first qualifying worsening event on Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part IITime frame: Up to 48 Weeks
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Site-049
Birmingham, Alabama · Recruiting
Site-079
Sun City, Arizona · Recruiting
Site-003
Irvine, California · Recruiting
Site-041
Los Angeles, California · Recruiting
Site-025
Aurora, Colorado · Recruiting
Site-031
Farmington, Connecticut · Recruiting
Site-028
New Haven, Connecticut · Recruiting
Site-038
Atlantis, Florida · Recruiting
Site-017
Boca Raton, Florida · Recruiting
Site-051
Maitland, Florida · Recruiting
Site-027
Chicago, Illinois · Recruiting
Site-029
Kansas City, Kansas · Recruiting
Site-071
Boston, Massachusetts · Recruiting
Site-004
Foxborough, Massachusetts · Recruiting
Site-015
Farmington Hills, Michigan · Recruiting
Site-044
Chesterfield, Missouri · Recruiting
Site-006
Albany, New York · Recruiting
Site-005
New York, New York · Recruiting
Site-082
Cleveland, Ohio · Recruiting
Site-091
Portland, Oregon · Recruiting
Site-043
Round Rock, Texas · Recruiting
Site-009
Henrico, Virginia · Recruiting
Site-074
Newport News, Virginia · Recruiting
Site-007
Bellevue, Washington · Recruiting
Site-019
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.